Carolyn M Tastad Procter & Gamble CO (PG) insider trading activity

Carolyn M Tastad is CEO - Health Care of PROCTER & GAMBLE Co. Currently has a direct ownership of 28,156 shares of PG, which is worth approximately $4.71 Million. The most recent transaction as insider was on Jan 28, 2020, when has been sold 37,385 shares (Common Stock) at a price of $78.86 per share, resulting in proceeds of $2,948,181. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28.2K

0% 3M change

0% 12M change

Total Value Held $4.71 Million

CAROLYN M TASTAD Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 28 2020	BUY Exercise of conversion of derivative security	$2,948,181 $78.86 p/Share	37,385 Added 29.48%	89,430 Common Stock
Nov 27 2019	SELL Bona fide gift	-	335 Reduced 0.55%	60,190 Common Stock
Nov 20 2019	SELL Payment of exercise price or tax liability	$114,999 $121.95 p/Share	943 Reduced 1.53%	60,525 Common Stock
Nov 20 2019	BUY Exercise of conversion of derivative security	$7,805 $121.95 p/Share	64 Added 0.11%	60,589 Common Stock
Aug 26 2019	SELL Open market or private sale	$1,258,116 $118.0 p/Share	10,662 Reduced 14.83%	61,225 Common Stock
Aug 20 2019	SELL Open market or private sale	$1,128,995 $119.8 p/Share	9,424 Reduced 11.59%	71,887 Common Stock
Aug 20 2019	BUY Grant, award, or other acquisition	-	20,086 Added 19.81%	81,311 Common Stock
May 22 2019	SELL Open market or private sale	$2,720,422 $106.08 p/Share	25,645 Reduced 29.58%	61,041 Common Stock
May 22 2019	BUY Exercise of conversion of derivative security	$1,752,579 $68.34 p/Share	25,645 Added 22.83%	86,686 Common Stock
May 01 2019	SELL Open market or private sale	$421,283 $105.85 p/Share	3,980 Reduced 6.14%	60,840 Common Stock
Feb 28 2019	SELL Open market or private sale	$147,165 $98.57 p/Share	1,493 Reduced 2.72%	53,302 Common Stock
Feb 28 2019	BUY Grant, award, or other acquisition	-	11,518 Added 15.09%	64,820 Common Stock
Nov 28 2018	SELL Open market or private sale	$1,834,626 $92.7 p/Share	19,791 Reduced 26.58%	54,672 Common Stock
Nov 28 2018	BUY Exercise of conversion of derivative security	$1,250,000 $63.16 p/Share	19,791 Added 22.4%	68,560 Common Stock
Nov 20 2018	SELL Open market or private sale	$65,310 $93.3 p/Share	700 Reduced 1.26%	54,672 Common Stock
Nov 20 2018	BUY Exercise of conversion of derivative security	$44,296 $63.28 p/Share	700 Added 1.25%	55,372 Common Stock
Nov 19 2018	SELL Bona fide gift	-	214 Reduced 0.39%	54,672 Common Stock
Nov 15 2018	SELL Open market or private sale	$580,410 $92.94 p/Share	6,245 Reduced 10.24%	54,756 Common Stock
Nov 14 2018	SELL Open market or private sale	$860,525 $93.07 p/Share	9,246 Reduced 13.16%	61,001 Common Stock
Nov 14 2018	BUY Exercise of conversion of derivative security	$546,901 $59.15 p/Share	9,246 Added 12.13%	67,001 Common Stock
Aug 22 2018	SELL Open market or private sale	$349,197 $83.52 p/Share	4,181 Reduced 6.41%	61,001 Common Stock
Aug 22 2018	BUY Grant, award, or other acquisition	-	10,426 Added 13.79%	65,182 Common Stock
Aug 06 2018	SELL Payment of exercise price or tax liability	$5,617 $81.41 p/Share	69 Reduced 0.13%	54,609 Common Stock
Aug 06 2018	BUY Exercise of conversion of derivative security	$5,617 $81.41 p/Share	69 Added 0.13%	54,678 Common Stock
Aug 02 2018	SELL Open market or private sale	$1,337,715 $81.0 p/Share	16,515 Reduced 23.22%	54,609 Common Stock

Also insider at

KELLOGG CO Consumer Defensive

Director

CMT

Carolyn M Tastad

CEO - Health Care

Cincinnati, OH

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PG shares.

Notify only if

Value

Insider Trading

Get notified when an Procter & Gamble CO insider buys or sells PG shares.

Notify only if

Operation

Value

Type

News

Receive news related to PROCTER & GAMBLE Co

Track Activities on PG

Account